神经的mTORC1抑制促进长寿,而不会抑制C. elegans的合成生长和繁殖
Hannah J Smith1, Anne Lanjuin1, Arpit Sharma1
1Dept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.
PLoS genetics
|September 18, 2023
概括
在神经元中准拉巴素复合体1 (mTORC1) 的机械标可以在没有负面副作用的情况下延长C. elegans的寿命. 这一发现表明神经元特异的mTORC1调制可能促进健康的衰老.
科学领域:
- 细胞生物学 细胞生物学
- 衰老研究研究 衰老研究
- 神经科学是一个神经科学.
背景情况:
- 拉巴胺素复合体1 (mTORC1) 的机械标是调节生长和细胞过程的关键代谢传感器.
- 系统性抑制mTORC1可以延长寿命,但会导致有害的类效应,如生长和生育能力受损.
- 目前尚不清楚mTORC1抑制对长寿的益处是否可以与其负面影响分开.
研究的目的:
- 为了研究抑制特定于神经元中的mTORC1是否可以在没有不良影响的情况下延长寿命.
- 确定mTORC1抑制对寿命的有益影响是否与其对生长,发育和繁殖的影响相分离.
主要方法:
- 在C. elegans中利用了辅酶诱导降解 (AID) 系统来实现mTORC1组件 (RAGA-1或LET-363) 的神经元特异性抑制.
- 将神经元RAGA-1降解与RAGA-1遗传突变和体质AID的影响进行了比较.
- 分析了寿命,体型,发育率,幼大小,神经元功能和基因表达特征.
主要成果:
- 神经元特异性降解RAGA-1或LET-363显著延长了C. elegans的寿命.
- 神经抑制RAGA-1可以延长寿命,而不会影响身体大小,发育,生育或神经功能.
- 系统RAGA-1降解影响了数千个基因,而神经元RAGA-1降解仅影响了大约200个基因,丰富了新陈代谢和应激反应途径.
结论:
- 专门针对神经元中的mTORC1将长寿与C. elegans的生长和生殖障碍脱离.
- 减少mTORC1活动的正规效应对于促进健康衰老并不重要.
- 神经元特异的mTORC1调制为促进长寿和健康衰老提供了一个有希望的策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


